Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, Fujimoto N, Sato H, Seiki M, Okada Y
Department of Pathology, School of Medicine, Keio University, Tokyo, Japan.
Cancer Res. 1999 Jan 15;59(2):467-73.
Matrix metalloproteinases (MMPs) are believed to be involved in the invasion and metastasis of various human carcinomas. In the present study, the production levels of seven different MMPs (MMP-1, -2, -3, -7, -8, -9, and -13), the activation of the zymogen of MMP-2 (proMMP-2), the expression of membrane-type MMPs (MT1-, MT2-, and MT3-MMPs), and the tissue localization of the activated enzyme were examined in human invasive papillary thyroid carcinomas. Sandwich enzyme immunoassays revealed that among the MMPs examined, only the MMP-2 production level is significantly enhanced in the carcinoma tissues compared with the follicular adenoma and normal control thyroid tissues. Gelatin zymography indicated that the proMMP-2 activation ratio is considerably higher in carcinomas with lymph node metastasis than it is in those without metastasis, follicular adenomas, or normal controls (P < 0.01). Northern blot analysis of the expression of MT1-, MT2-, and MT3-MMPs, which are known to activate proMMP-2 in vitro, demonstrated the predominant expression of MT1-MMP mRNA in the carcinoma tissues (15 of 15 cases), whereas MT2-MMP expression was confined to 26% of the cases (4 of 15 cases), and no consistent expression of MT3-MMP was observed. MTI-MMP mRNA expression levels correlated with the proMMP-2 activation ratio (r = 0.692; P < 0.01), but such a correlation was not obtained with MT2-MMP. There was also a direct correlation between MT1-MMP expression and lymph node metastasis (P < 0.05). In situ hybridization indicated that both carcinoma and stromal cells express MT1-MMP transcripts (five of six cases). MT1-MMP was also immunolocalized to carcinoma and stromal cells in all of the carcinoma samples (26 of 26 cases), which were positive for MMP-2. In situ zymography indicated definite gelatinolytic activity in the carcinoma cell nests, which was abolished by incubation of the carcinoma samples with a synthetic MMP inhibitor before the reaction. These results suggest for the first time that among seven different MMPs, the production of proMMP-2 and its MT1-MMP-mediated activation in the carcinoma cell nests play an important role in the lymph node metastasis of human invasive papillary thyroid carcinomas.
基质金属蛋白酶(MMPs)被认为参与了多种人类癌症的侵袭和转移。在本研究中,检测了7种不同MMPs(MMP-1、-2、-3、-7、-8、-9和-13)的产生水平、MMP-2酶原(proMMP-2)的激活、膜型MMPs(MT1-MMP、MT2-MMP和MT3-MMP)的表达以及活化酶在人侵袭性乳头状甲状腺癌中的组织定位。夹心酶免疫分析显示,在所检测的MMPs中,与滤泡性腺瘤和正常对照甲状腺组织相比,仅癌组织中的MMP-2产生水平显著升高。明胶酶谱分析表明,有淋巴结转移的癌组织中proMMP-2的激活率显著高于无转移的癌组织、滤泡性腺瘤或正常对照(P<0.01)。已知MT1-MMP、MT2-MMP和MT3-MMP在体外可激活proMMP-2,对其表达进行Northern印迹分析显示,癌组织中MT1-MMP mRNA呈优势表达(15例中有15例),而MT2-MMP表达仅见于26%的病例(15例中有4例),未观察到MT3-MMP的一致性表达。MT1-MMP mRNA表达水平与proMMP-2激活率相关(r=0.692;P<0.01),而与MT2-MMP无此相关性。MT1-MMP表达与淋巴结转移之间也存在直接相关性(P<0.05)。原位杂交表明,癌组织和基质细胞均表达MT1-MMP转录本(6例中有5例)。在所有MMP-2阳性的癌组织样本(26例中有26例)中,MT1-MMP也定位于癌组织和基质细胞。原位酶谱分析表明,癌细胞巢中有明确的明胶溶解活性,在反应前用合成MMP抑制剂孵育癌组织样本可消除该活性。这些结果首次表明,在7种不同的MMPs中,癌组织中proMMP-2的产生及其MT1-MMP介导的激活在人侵袭性乳头状甲状腺癌的淋巴结转移中起重要作用。